Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ADGRL3 (LPHN3) variants predict substance use disorder.
Arcos-Burgos M, Vélez JI, Martinez AF, Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, Richarte V, Roncero C, Cormand B, Fernández-Castillo N, Casas M, Lopera F, Pineda DA, Palacio JD, Acosta-López JE, Cervantes-Henriquez ML, Sánchez-Rojas MG, Puentes-Rozo PJ, Molina BSG; MTA Cooperative Group; Boden MT, Wallis D, Lidbury B, Newman S, Easteal S, Swanson J, Patel H, Volkow N, Acosta MT, Castellanos FX, de Leon J, Mastronardi CA, Muenke M. Arcos-Burgos M, et al. Among authors: wallis d. Transl Psychiatry. 2019 Jan 29;9(1):42. doi: 10.1038/s41398-019-0396-7. Transl Psychiatry. 2019. PMID: 30696812 Free PMC article.
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication.
Arcos-Burgos M, Jain M, Acosta MT, Shively S, Stanescu H, Wallis D, Domené S, Vélez JI, Karkera JD, Balog J, Berg K, Kleta R, Gahl WA, Roessler E, Long R, Lie J, Pineda D, Londoño AC, Palacio JD, Arbelaez A, Lopera F, Elia J, Hakonarson H, Johansson S, Knappskog PM, Haavik J, Ribases M, Cormand B, Bayes M, Casas M, Ramos-Quiroga JA, Hervas A, Maher BS, Faraone SV, Seitz C, Freitag CM, Palmason H, Meyer J, Romanos M, Walitza S, Hemminger U, Warnke A, Romanos J, Renner T, Jacob C, Lesch KP, Swanson J, Vortmeyer A, Bailey-Wilson JE, Castellanos FX, Muenke M. Arcos-Burgos M, et al. Among authors: wallis d. Mol Psychiatry. 2010 Nov;15(11):1053-66. doi: 10.1038/mp.2010.6. Epub 2010 Feb 16. Mol Psychiatry. 2010. PMID: 20157310 Free article.
Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci.
Jain M, Palacio LG, Castellanos FX, Palacio JD, Pineda D, Restrepo MI, Muñoz JF, Lopera F, Wallis D, Berg K, Bailey-Wilson JE, Arcos-Burgos M, Muenke M. Jain M, et al. Among authors: wallis d. Biol Psychiatry. 2007 Jun 15;61(12):1329-39. doi: 10.1016/j.biopsych.2006.06.026. Epub 2006 Sep 1. Biol Psychiatry. 2007. PMID: 16950213
Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility.
Domené S, Stanescu H, Wallis D, Tinloy B, Pineda DE, Kleta R, Arcos-Burgos M, Roessler E, Muenke M. Domené S, et al. Among authors: wallis d. Am J Med Genet B Neuropsychiatr Genet. 2011 Jan;156B(1):11-8. doi: 10.1002/ajmg.b.31141. Epub 2010 Nov 12. Am J Med Genet B Neuropsychiatr Genet. 2011. PMID: 21184580
Molecular mechanisms of holoprosencephaly.
Wallis DE, Muenke M. Wallis DE, et al. Mol Genet Metab. 1999 Oct;68(2):126-38. doi: 10.1006/mgme.1999.2895. Mol Genet Metab. 1999. PMID: 10527664 Free article. Review.
Locus homogeneity between syndactyly type 1A and craniosynostosis Philadelphia type?
Jain M, Wallis D, Robin NH, De Vrieze FW, Hardy JA, Ghadami M, Bosse K, Betz RC, Nöthen MM, Arcos-Burgos M, Muenke M. Jain M, et al. Among authors: wallis d. Am J Med Genet A. 2008 Sep 1;146A(17):2308-11. doi: 10.1002/ajmg.a.32445. Am J Med Genet A. 2008. PMID: 18680190 Free PMC article. No abstract available.
Mutations in holoprosencephaly.
Wallis D, Muenke M. Wallis D, et al. Hum Mutat. 2000;16(2):99-108. doi: 10.1002/1098-1004(200008)16:2<99::AID-HUMU2>3.0.CO;2-0. Hum Mutat. 2000. PMID: 10923031 Review.
292 results